Featured Research

from universities, journals, and other organizations

HOPE Act passes: May help reduce U. S. organ shortage

Date:
November 13, 2013
Source:
American Society of Nephrology (ASN)
Summary:
The HOPE Act could allow individuals with HIV to receive organ transplants from donors with HIV, and may help reduce the country’s current organ shortage.

Congress has passed legislation to end the federal ban on the transplantation of organs from deceased HIV-positive donors to patients with HIV. The American Society of Nephrology (ASN) worked closely with Congress and other organizations to promote the HIV Organ Policy Equity (HOPE) Act. This milestone legislation could add up to 600 organs per year for HIV-infected transplant candidates and expand the total pool of available organs.

Because the HOPE Act will pave the way for research into positive-to-positive transplants, patients with HIV should one day get faster access to a new supply of organs. While HIV is no longer a death sentence, kidney and liver failure is now a leading cause of death of HIV-positive patients.

"This legislation will preserve valuable organs and save lives by establishing guidelines for HIV+ to HIV+ transplants," said Michelle Josephson, MD, who leads the ASN Transplant Advisory Group.

Other patients on the transplant list will also benefit from expanding the pool of available organs. "The HOPE Act could reduce waiting times for a life-saving transplant, which is why ASN so passionately advocated its passage," said ASN President Sharon Moe, MD, FASN.

Shamey Cramer, a patient advocate who has been living with HIV for nearly 30 years and was instrumental in advocacy efforts, notes the law will help all patients, both with and without HIV. "The HOPE Act really does give new hope to all patients who are waiting for the gift of life."

While the HOPE Act does not directly affect federal spending, it has the potential to decrease Medicare spending by providing more opportunities for patients to move off dialysis and receive a kidney transplant.


Story Source:

The above story is based on materials provided by American Society of Nephrology (ASN). Note: Materials may be edited for content and length.


Cite This Page:

American Society of Nephrology (ASN). "HOPE Act passes: May help reduce U. S. organ shortage." ScienceDaily. ScienceDaily, 13 November 2013. <www.sciencedaily.com/releases/2013/11/131113092132.htm>.
American Society of Nephrology (ASN). (2013, November 13). HOPE Act passes: May help reduce U. S. organ shortage. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2013/11/131113092132.htm
American Society of Nephrology (ASN). "HOPE Act passes: May help reduce U. S. organ shortage." ScienceDaily. www.sciencedaily.com/releases/2013/11/131113092132.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins